Fund shareholders of MoonLake Immunotherapeutics
ISIN KY61559X1045 · Cayman Islands
- Fund shareholders
- 52
- Of which ETFs
- 14 38 other funds
- Value held
- ≈ 106.9M $ 106.8M $ · 36.7K €
52 funds hold this company. This table lists the 51 that declare it in a regulatory filing. 1 more fund publishes its holdings in its own report. The “Fund reports” tab lists it, with its weight.
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| T. Rowe Price Capital Appreciation Fund T. ROWE PRICE CAPITAL APPRECIATION FUND, INC. | 1,614,289 | 31.4M $ | 0.04 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Small-Cap Value Fund, Inc. T. ROWE PRICE SMALL-CAP VALUE FUND, INC. | 918,586 | 17.9M $ | 0.17 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 792,072 | 15.4M $ | 0.13 % | as of Jun 30, 2026 ↗ |
| JNL/T. Rowe Price Capital Appreciation Fund JNL Series Trust | 350,134 | 6.8M $ | 0.04 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Capital Appreciation Equity ETF T. Rowe Price Exchange-Traded Funds, Inc. | 167,768 | 3.3M $ | 0.04 % | as of Jun 30, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 161,391 | 3.1M $ | 0.05 % | as of May 29, 2026 ↗ |
| VY(R) T. ROWE PRICE CAPITAL APPRECIATION PORTFOLIO Voya Investors Trust | 160,298 | 3.1M $ | 0.04 % | as of Jun 30, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 143,558 | 2.8M $ | 0.05 % | as of May 31, 2026 ↗ |
| Penn Series Flexibly Managed Fund Penn Series Funds Inc | 111,792 | 2.2M $ | 0.04 % | as of Jun 30, 2026 ↗ |
| Nomura Healthcare Fund Delaware Group Equity Funds IV | 110,000 | 2.1M $ | 0.29 % | as of Jun 30, 2026 ↗ |
| JNL Multi-Manager Small Cap Value Fund JNL Series Trust | 109,447 | 2.1M $ | 0.11 % | as of Jun 30, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 94,919 | 1.8M $ | 0.01 % | as of May 31, 2026 ↗ |
| Invesco Dorsey Wright SmallCap Momentum ETF Invesco Exchange-Traded Fund Trust II | 80,780 | 1.5M $ | 0.37 % | as of May 31, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 73,934 | 1.4M $ | 0.88 % | as of May 31, 2026 ↗ |
| iShares ESG Aware MSCI USA Small-Cap ETF iShares Trust | 65,400 | 1.3M $ | 0.05 % | as of May 31, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 55,515 | 1.1M $ | 0.14 % | as of Jun 30, 2026 ↗ |
| Small Cap Value Portfolio NORTHWESTERN MUTUAL SERIES FUND INC | 50,010 | 973.7K $ | 0.15 % | as of Jun 30, 2026 ↗ |
| Victory Small Cap Stock Fund Victory Portfolios III | 45,833 | 845.2K $ | 0.09 % | as of Jul 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 43,692 | 838K $ | 0.00 % | as of May 31, 2026 ↗ |
| SMALL CAP EQUITY FUND GuideStone Funds | 34,570 | 673.1K $ | 0.06 % | as of Jun 30, 2026 ↗ |
| Nuveen ESG Small-Cap ETF NuShares ETF Trust | 34,135 | 629.4K $ | 0.05 % | as of Jul 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust | 30,712 | 589.1K $ | 0.01 % | as of May 31, 2026 ↗ |
| Optimize Strategy Index ETF Advisor Managed Portfolios | 24,335 | 473.8K $ | 0.17 % | as of Jun 30, 2026 ↗ |
| JNL/T. Rowe Price Capital Appreciation Equity Fund JNL Series Trust | 23,859 | 464.5K $ | 0.04 % | as of Jun 30, 2026 ↗ |
| AZL T Rowe Price Capital Appreciation Fund Allianz Variable Insurance Products Trust | 20,914 | 407.2K $ | 0.04 % | as of Jun 30, 2026 ↗ |
| Fidelity MSCI Health Care Index ETF FIDELITY COVINGTON TRUST | 20,634 | 380.5K $ | 0.01 % | as of Jul 31, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 17,234 | 335.5K $ | 0.13 % | as of Jun 30, 2026 ↗ |
| BlackRock Advantage SMID Cap Fund, Inc. BlackRock Advantage SMID Cap Fund, Inc. | 17,063 | 332.2K $ | 0.03 % | as of Jun 30, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 16,630 | 306.7K $ | 0.66 % | as of Jul 31, 2026 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 14,014 | 272.9K $ | 0.15 % | as of Jun 30, 2026 ↗ |
| Small Company Value Trust John Hancock Variable Insurance Trust | 11,340 | 220.8K $ | 0.15 % | as of Jun 30, 2026 ↗ |
| Capital Appreciation Value Trust John Hancock Variable Insurance Trust | 11,317 | 220.3K $ | 0.04 % | as of Jun 30, 2026 ↗ |
| Clearwater Select Equity Fund Clearwater Investment Trust | 10,515 | 204.7K $ | 0.04 % | as of Jun 30, 2026 ↗ |
| Health Sciences Portfolio PACIFIC SELECT FUND | 9,574 | 186.4K $ | 0.05 % | as of Jun 30, 2026 ↗ |
| ACUITAS US MICROCAP FUND FORUM FUNDS II | 8,800 | 171.3K $ | 0.15 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Health Care ETF T. Rowe Price Exchange-Traded Funds, Inc. | 7,823 | 152.3K $ | 0.66 % | as of Jun 30, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 7,308 | 134.8K $ | 0.02 % | as of Jul 31, 2026 ↗ |
| Small Cap Core Fund Northern Funds | 6,816 | 132.7K $ | 0.03 % | as of Jun 30, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 6,300 | 122.7K $ | 0.00 % | as of Jun 30, 2026 ↗ |
| BlackRock Advantage SMID Cap V.I. Fund BlackRock Variable Series Funds, Inc. | 4,705 | 91.6K $ | 0.05 % | as of Jun 30, 2026 ↗ |
| Harbor Active Small Cap Growth ETF Harbor ETF Trust | 4,489 | 82.8K $ | 0.31 % | as of Jul 31, 2026 ↗ |
| Capital Appreciation Portfolio PACIFIC SELECT FUND | 3,350 | 65.2K $ | 0.04 % | as of Jun 30, 2026 ↗ |
| JNL/DFA U.S. Small Cap Fund JNL Series Trust | 2,307 | 44.9K $ | 0.01 % | as of Jun 30, 2026 ↗ |
| Virtus AlphaSimplex Global Alternatives Fund Virtus Alternative Solutions Trust | 1,488 | 29K $ | 0.04 % | as of Jun 30, 2026 ↗ |
| iShares MSCI World Small-Cap ETF iShares Trust | 1,428 | 27.4K $ | 0.00 % | as of May 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 1,145 | 22.3K $ | 0.00 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Innovation Leaders ETF T. Rowe Price Exchange-Traded Funds, Inc. | 861 | 16.8K $ | 0.09 % | as of Jun 30, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 301 | 5.6K $ | 0.00 % | as of Jul 31, 2026 ↗ |
| Innovator U.S. Small Cap Managed 10 Buffer ETF Innovator ETFs Trust | 274 | 5.1K $ | 0.05 % | as of Jul 31, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 10 | 184.4 $ | 0.00 % | as of Jul 31, 2026 ↗ |
| A&P LIFESCIENCE FUND, FI WELZIA MANAGEMENT, SGIIC, S.A. | 36.7K € | 1.00 % | as of Dec 31, 2025 ↗ |
Funds that publish their own holdings
| Fund | Weight in fund | |
|---|---|---|
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 0.03 % | as of Sep 30, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| A&P LIFESCIENCE FUND, FI WELZIA MANAGEMENT, SGIIC, S.A. | 1.00 % | as of Dec 31, 2025 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 0.88 % | as of May 31, 2026 ↗ |
| T. Rowe Price Health Care ETF T. Rowe Price Exchange-Traded Funds, Inc. | 0.66 % | as of Jun 30, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 0.66 % | as of Jul 31, 2026 ↗ |
| Invesco Dorsey Wright SmallCap Momentum ETF Invesco Exchange-Traded Fund Trust II | 0.37 % | as of May 31, 2026 ↗ |
| Harbor Active Small Cap Growth ETF Harbor ETF Trust | 0.31 % | as of Jul 31, 2026 ↗ |
| Nomura Healthcare Fund Delaware Group Equity Funds IV | 0.29 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Small-Cap Value Fund, Inc. T. ROWE PRICE SMALL-CAP VALUE FUND, INC. | 0.17 % | as of Jun 30, 2026 ↗ |
| Optimize Strategy Index ETF Advisor Managed Portfolios | 0.17 % | as of Jun 30, 2026 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 0.15 % | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 50 | +18 | 5,503,669 | +191.6 % |
| 2026Q2 | 32 | -4 | 1,887,569 | -21.4 % |
| 2026Q1 | 36 | -19 | 2,400,998 | -50.8 % |
| 2025Q4 | 55 | -59 | 4,883,886 | -59.5 % |
| 2025Q3 | 114 | +8 | 12,057,051 | -8.0 % |
| 2025Q2 | 106 | 0 | 13,111,725 | +0.1 % |
| 2025Q1 | 106 | -2 | 13,098,345 | +14.1 % |
| 2024Q4 | 108 | +9 | 11,484,739 | +24.8 % |
| 2024Q3 | 99 | -16 | 9,203,952 | -4.2 % |
| 2024Q2 | 115 | +13 | 9,604,828 | +7.7 % |
| 2024Q1 | 102 | +4 | 8,914,871 | -3.9 % |
| 2023Q4 | 98 | 9,280,556 |
Cite this page
Titelia. "Fund shareholders of MoonLake Immunotherapeutics". https://titelia.com/en/stocks/moonlake-immunotherapeutics-KY61559X1045